Evidence map›Paper›PMID 32079062›Full record

ArticleMicromachines2020

Integrated Microfluidic Preconcentration and Nucleic Amplification System for Detection of Influenza A Virus H1N1 in Saliva.

Yonghee Kim, Abdurhaman Teyib Abafogi, Buu Minh Tran, Jaewon Kim, Jinyeop Lee, Zhenzhong Chen, Pan Kee Bae, Kyoungsook Park, Yong-Beom Shin, Danny van Noort and 2 more

Abstract read
In one paragraph

Article in Micromachines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Microfluidic devices for detection of RNA viruses.Reviews in medical virology · 2021
    Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yonghee KimSchool of Mechanical Engineering, Sungkyunkwan University, Suwon 16419, Korea.
Abdurhaman Teyib AbafogiSchool of Mechanical Engineering, Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0001-5679-1401
Buu Minh TranDepartment of BioNano Technology, College of BioNano Technology, Gachon University, Seongnam 13120, Korea.ORCID 0000-0002-3440-8974
Jaewon KimSchool of Mechanical Engineering, Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0001-9793-9046
Jinyeop LeeSchool of Mechanical Engineering, Sungkyunkwan University, Suwon 16419, Korea.
Zhenzhong ChenSchool of Mechanical Engineering, Sungkyunkwan University, Suwon 16419, Korea.
Pan Kee BaeBioNano Health Guard Research Center (H-GUARD), Daejeon 34141, Korea.
Kyoungsook ParkBioNano Health Guard Research Center (H-GUARD), Daejeon 34141, Korea.
Yong-Beom ShinBioNano Health Guard Research Center (H-GUARD), Daejeon 34141, Korea.
Danny van NoortDepartment of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.ORCID 0000-0002-0818-0443
Nae Yoon LeeDepartment of BioNano Technology, College of BioNano Technology, Gachon University, Seongnam 13120, Korea.
Sungsu ParkSchool of Mechanical Engineering, Sungkyunkwan University, Suwon 16419, Korea.

Funding

Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica FONDECYT 042-2019H2020 Spreading Excellence and Widening Participation 811040National Research Foundation of Korea NRF-2018M3A6B2057299
6 · The paper itself

Abstract

Influenza A viruses are often present in environmental and clinical samples at concentrations below the limit of detection (LOD) of molecular diagnostics. Here we report an integrated microfluidic preconcentration and nucleic amplification system (μFPNAS) which enables both preconcentration of influenza A virus H1N1 (H1N1) and amplification of its viral RNA, thereby lowering LOD for H1N1. H1N1 virus particles were first magnetically preconcentrated using magnetic nanoparticles conjugated with an antibody specific for the virus. Their isolated RNA was amplified to cDNA through thermocycling in a trapezoidal chamber of the μFPNAS. A detection limit as low as 100 TCID50 (50% tissue culture infective dose) in saliva can be obtained within 2 hours. These results suggest that the LOD of molecular diagnostics for virus can be lowered by systematically combining immunomagnetic separation and reverse transcriptase-polymerase chain reaction (RT-PCR) in one microfluidic device.

Indexed as

H1N1immunomagnetic separationmicrofluidic devicemolecular amplification

Identifiers

PMID32079062
PMCPMC7074655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.